Search

everythinglearnresearchcommunity

for

Search:↓

Mice with a specific BRCA1 mutation have a higher risk of tumors, especially in the uterus and ovaries.

A specific gene mutation in KRT86 is linked to hair disorder in a Chinese Han family.

The study created a mouse model to better understand hair follicle stem cells' role in hair growth and repair.

Coinheritance of BRCA2 and CYLD genes may lead to new treatment options for certain cancers.

Protein Kinase Cε increases skin sensitivity to UV damage and skin cancer risk.

Deleting vitamin D and calcium receptors in skin cells increases skin cancer risk by reducing DNA repair and stress response.

KRTAP2-3 could help predict cancer recurrence by identifying specific cancer cells.

WNT10A helps esophageal cancer cells spread and keep renewing themselves.

Cancer-associated fibroblasts promote tumor growth in skin cancer.

A specific gene mutation causes severe skin and nail issues and hair loss.

Polyamines are crucial for skin tumor development, and inhibiting them can prevent tumors.

Keratoacanthoma is a common, usually non-dangerous skin tumor that looks like squamous cell carcinoma but rarely becomes severe.

A specific ATR gene mutation is linked to a hereditary oropharyngeal cancer syndrome.

Cancer cells often have more copies of TERT and TERC genes, which helps them grow and could affect patient outcomes.

Targeting ACE2 and TMPRSS2 may help prevent or treat COVID-19 in cancer patients.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Androgen receptor overexpression can increase prostate cancer cell growth even without hormones.

Keratin 17 is linked to various diseases, including cancer and skin conditions, and may be a target for diagnosis and treatment.

Keratins are crucial for tissue strength, and mutations in keratin genes can lead to various diseases, highlighting the need for targeted therapies.

Mouse skin cancer progression involves a unique group of cells marked by ABCG2 and MTS24.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

The document concludes that the development of certain tumors is influenced by genetic background and that a specific gene modification can lead to tumor regression and reduced growth.

Suppressing ODC activity reduces tumor growth in hair follicles.

CREB, a protein that can promote cancer traits, is controlled by β-catenin in skin cancer cells.

Skin lesions in Carney Complex are caused by a gene change in some skin cells that leads to increased pigmentation and may lead to tumors.

A new mutation in the KRT86 gene causes a hair disorder with variable expression.

Recognizing RSCC is crucial due to its aggressive nature and high risk of poor outcomes.

A woman with a new PTCH gene mutation has both Gorlin syndrome and severe hair loss.

KIT's role in skin cells is not entirely independent, as other cells can influence its function.